# Bayer financial and glyphosate litigation management

> Live situation record from CLSTR: https://clstr.news/situations/bayer-financial-and-glyphosate-litigation-management
> Updated: 2026-09-23T12:14:49.000Z. Sources: 8. Developments: 2.

Bayer is navigating financial and legal pressures related to its glyphosate-based products in the United States. Initially, the company’s stock experienced volatility and sideways movement on the XETRA exchange as investors awaited legal developments regarding glyphosate.

To manage high debt levels and significant legal costs, Bayer issued 2 billion euros in hybrid bonds, bringing its total outstanding hybrid bonds to 6.55 billion euros. This financing strategy is intended to provide financial flexibility and fund legal settlements, including a previous preliminary settlement valued at approximately 7.25 billion dollars, while mitigating impacts on the company’s credit rating.

## Timeline

### 2026-09-23: Bayer raises 2 billion euros through hybrid bond issuance

Bayer has issued 2 billion euros in 30-year hybrid bonds to bolster financial flexibility amid high debt and ongoing US glyphosate-related litigation.

6 sources. https://clstr.news/cluster/bayer-raises-over-2-billion-euros-through-hybrid-bonds

### 2026-09-13: Bayer stock faces volatility ahead of US glyphosate legal developments

Bayer stock remains in a sideways trading pattern as investors await critical legal developments regarding glyphosate in the United States.

2 sources. https://clstr.news/cluster/bayer-stock-faces-volatility-ahead-of-us-glyphosate-legal-developments

---
Cite as: Bayer financial and glyphosate litigation management. CLSTR, https://clstr.news/situations/bayer-financial-and-glyphosate-litigation-management